Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
254.00    0.20 (0.08%)
Bid:
253.60
Ask:
254.00
Spread: 0.40 (0.158%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Serco share repurchase programme

28 Feb 2023 11:30

RNS Number : 2131R
Serco Group PLC
28 February 2023
Β 

Serco share repurchase programme

Β 

28 February 2023

Serco Group plc

LEI: 549300PT2CIHYN5GWJ21

Β 

Serco today provides this further announcement in connection with its intention to repurchase shares over the next 10 months valued at up to Β£90 million (the "Programme"), as announced on 28 February 2023.

Β 

This will occur during the period starting on 1 March 2023 and ending no later than 29 December 2023 (the 'Engagement Period'). The aggregate number of shares acquired by the Company shall not exceed the balance of 76,128,175 shares remaining of the 121,800,878 shares authorised by shareholders at the 2022 Annual General Meeting, or any amount subsequently approved by shareholders at the 2023 Annual General Meeting. It is intended that the shares repurchased under the Programme will be transferred into treasury.

Β 

The Company has entered into an agreement with J.P. Morgan Securities plc ('JPMS plc') under which it has issued an irrevocable instruction to JPMS plc to manage the Programme for the Engagement Period. JPMS plc will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares.

Β 

JPMS plc may undertake transactions in ordinary shares of the Company (which may include sales and hedging activities, in addition to purchases which may take place on any available trading venue or on an over the counter basis) during the Engagement Period in order to manage its market exposure under the Programme. Disclosure of such transactions will not be made by JPMS plc as a result of or as part of the Programme, but JPMS plc will continue to make any disclosures it is otherwise legally required to make.

Β 

Ends

Β 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com

Β 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCMZGZZLNRGFZM
Date   Source Headline
31st Mar 20227:00 amRNSTransaction in Own Shares
30th Mar 20223:07 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSTransaction in Own Shares
29th Mar 20227:00 amRNSTransaction in Own Shares
28th Mar 20227:00 amRNSTransaction in Own Shares
25th Mar 20227:00 amRNSTransaction in Own Shares
24th Mar 20227:00 amRNSTransaction in Own Shares
23rd Mar 20227:00 amRNSTransaction in Own Shares
22nd Mar 20227:00 amRNSTransaction in Own Shares
21st Mar 20223:41 pmRNSNotice of AGM
21st Mar 20227:00 amRNSTransaction in Own Shares
18th Mar 20227:00 amRNSTransaction in Own Shares
17th Mar 20227:00 amRNSTransaction in Own Shares
16th Mar 20227:00 amRNSTransaction in Own Shares
15th Mar 20227:00 amRNSTransaction in Own Shares
11th Mar 20227:00 amRNSTransaction in Own Shares
10th Mar 20227:00 amRNSTransaction in Own Shares
9th Mar 20227:00 amRNSTransaction in Own Shares
8th Mar 202212:24 pmRNSAnnual Financial Report
8th Mar 20227:00 amRNSShare Repurchase
1st Mar 202210:05 amRNSTotal Voting Rights
24th Feb 20227:00 amRNS2021 Full Year Results
15th Feb 202211:57 amRNSHolding(s) in Company
10th Feb 20229:52 amRNSHolding(s) in Company
1st Feb 20223:30 pmRNSTotal Voting Rights
26th Jan 202210:10 amRNSHolding(s) in Company
24th Jan 20222:51 pmRNSHolding(s) in Company
20th Jan 20221:42 pmRNSHolding(s) in Company
20th Jan 20221:00 pmRNSDirector Declaration
4th Jan 202210:00 amRNSTotal Voting Rights
24th Dec 202111:50 amRNSDirector/PDMR Shareholding
2nd Dec 20217:00 amRNSCapital Markets Event and initial 2022 guidance
1st Dec 202110:00 amRNSTotal Voting Rights
15th Nov 20217:00 amRNSTrading update
1st Nov 20219:39 amRNSTotal Voting Rights
25th Oct 202110:40 amRNSHolding(s) in Company
11th Oct 20213:07 pmRNSDirector Declaration
1st Oct 202110:06 amRNSTotal Voting Rights
24th Sep 202111:11 amRNSDirectorate Change
22nd Sep 20212:38 pmRNSDirector/PDMR Shareholding
1st Sep 20219:51 amRNSTotal Voting Rights
24th Aug 20214:17 pmRNSDirector/PDMR Shareholding
5th Aug 20217:00 amRNSHalf-year Report
2nd Aug 202110:08 amRNSTotal Voting Rights
2nd Jul 20217:00 amRNSDirector/PDMR Shareholding
1st Jul 202110:16 amRNSTotal Voting Rights
30th Jun 20217:00 amRNSClosed period trading update
29th Jun 202110:00 amRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSSerco wins Testing Centres contract rebid
28th Jun 20217:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.